Literature DB >> 23261761

Sustained attention in the elderly: what do we know and what does it tell us about cognitive aging?

Bérengère Staub1, Nadège Doignon-Camus, Olivier Després, Anne Bonnefond.   

Abstract

The ability to achieve and maintain the focus of cognitive activity on a given stimulation source or task, in other words to sustain attention or vigilance, is a fundamental component of human cognition. Given the omnipresent need for sustained attention in people's daily lives, a precise knowledge of the effects of normal aging on sustained attention is crucial. Findings in this topic are currently not consistent since they highlight either alteration or preservation or even the two, depending on the experimental approach used. Actually, the two existing approaches do not involve bottom-up and top-down processes at the same extent, which may in part account for this inconclusiveness. This review presents and attempts to explain these results by putting them into perspective with our current knowledge on cognitive aging and the two competing vigilance decrement theories, and discusses how they could inform us on our problems with sustaining attention over time.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23261761     DOI: 10.1016/j.arr.2012.12.001

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  17 in total

Review 1.  Recent theoretical, neural, and clinical advances in sustained attention research.

Authors:  Francesca C Fortenbaugh; Joseph DeGutis; Michael Esterman
Journal:  Ann N Y Acad Sci       Date:  2017-03-05       Impact factor: 5.691

2.  On the preservation of vigilant attention to semantic information in healthy aging.

Authors:  David R Thomson; Lynn Hasher
Journal:  Exp Brain Res       Date:  2017-05-05       Impact factor: 1.972

3.  BOLD neurovascular coupling does not change significantly with normal aging.

Authors:  Jack Grinband; Jason Steffener; Qolamreza R Razlighi; Yaakov Stern
Journal:  Hum Brain Mapp       Date:  2017-04-17       Impact factor: 5.038

4.  Evidence that ageing yields improvements as well as declines across attention and executive functions.

Authors:  João Veríssimo; Paul Verhaeghen; Noreen Goldman; Maxine Weinstein; Michael T Ullman
Journal:  Nat Hum Behav       Date:  2021-08-19

5.  Sustained Attention Across the Life Span in a Sample of 10,000: Dissociating Ability and Strategy.

Authors:  Francesca C Fortenbaugh; Joseph DeGutis; Laura Germine; Jeremy B Wilmer; Mallory Grosso; Kathryn Russo; Michael Esterman
Journal:  Psychol Sci       Date:  2015-08-07

6.  Tracking behavioral and neural fluctuations during sustained attention: A robust replication and extension.

Authors:  Francesca C Fortenbaugh; David Rothlein; Regina McGlinchey; Joseph DeGutis; Michael Esterman
Journal:  Neuroimage       Date:  2018-01-04       Impact factor: 6.556

7.  A neuropsychological instrument measuring age-related cerebral decline in older drivers: development, reliability, and validity of MedDrive.

Authors:  Paul Vaucher; Isabel Cardoso; Janet L Veldstra; Daniela Herzig; Michael Herzog; Patrice Mangin; Bernard Favrat
Journal:  Front Hum Neurosci       Date:  2014-10-09       Impact factor: 3.169

8.  Aging of Attentiveness in Border Collies and Other Pet Dog Breeds: The Protective Benefits of Lifelong Training.

Authors:  Durga Chapagain; Zsófia Virányi; Lisa J Wallis; Ludwig Huber; Jessica Serra; Friederike Range
Journal:  Front Aging Neurosci       Date:  2017-04-20       Impact factor: 5.750

9.  Applicability of the Test of Variables of Attention - T.O.V.A in Brazilian adults.

Authors:  Cláudia M Memória; Henrique C S Muela; Natália C Moraes; Valéria A Costa-Hong; Michel F Machado; Ricardo Nitrini; Luiz A Bortolotto; Monica S Yassuda
Journal:  Dement Neuropsychol       Date:  2018 Oct-Dec

Review 10.  Healthy Aging and Dementia: Two Roads Diverging in Midlife?

Authors:  Katie Irwin; Claire Sexton; Tarun Daniel; Brian Lawlor; Lorina Naci
Journal:  Front Aging Neurosci       Date:  2018-09-19       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.